Novexel

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

Cerexa

This biopharmaceutical company develops hospital-based anti-infective therapies for patients with serious and life-threatening infections.

Arpida AG

This biopharmaceutical company develops novel antibiotics for hospital patients to treat severe infections caused by drug-resistant bacteria.

Arpida

This company develops antimicrobial drugs and broad-spectrum antibiotics to treat patients with severe bacterial infections requiring hospital treatment.

TXN Systems

This pharmaceutical company develops a novel class of antibiotics to treat multidrug-resistant urinary tract infections in patients.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.